Going the Extra Mile - or Hundred - for Patients
In this month's episode, we'll hear from one extraordinary oncology nurse who ran 100 miles for cancer research.
A passion for running and helping her patients has led Angela Hammack, BSN, RN, OCN, to do great things. In 2017, Hammack, a charge nurse and clinical educator with Jackson Oncology Associates, ran a 100-mile race for cancer research and patient care. Her efforts continued after that, and to-date, she has raised over $100,000 for the cause.
For this month’s episode, we’ll hear from Hammack—who was also a finalist for CURE’s 2019 Extraordinary Healer Award—about what keeps her motivated.
First-Line Pembrolizumab Shows A Trend Towards Overall Survival in MSI-D/dMMR mCRC
December 2nd 2023The median overall survival was 77.5 months with frontline pembrolizumab vs 36.7 months with chemotherapy in patients with microsatellite instability–high or mismatch repair–deficient metastatic colorectal cancer.
FDA Grants Pirtobrutinib Accelerated Approval to Treat CLL/SLL in the Third Line
December 2nd 2023The FDA has approved the non-covalent BTK inhibitor, pirtobrutinib, to treat patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have already undergone 2 lines of therapy.
